|
Informed decision making requires researchers to connect information from a wide range of proprietary and public technologies ("-omics") used to shed light on disease mechanisms in a patient-centric environment.
Biomax provides a highly flexible and intuitive system which allows scientists to identify novel relationships and patterns between biomedical information networks and patient and clinical trial data ("Translational Sciences").
Reduced costs and improved productivity in a dynamic research environment are ensured by configuring the solution to your specific requirements and to reflect your decision-making process. This approach avoids cost-intensive development cycles, providing a high return on investment.
The BioXM, BioRS and BioLT systems provide an integrated solution for data analysis, data and knowledge management, knowledge generation and hypothesis modeling for a broad range of clinical research requirements.
Contact Biomax
|
The BioXM platform was used to build a knowledge base with human genetic and cancer gene information. This knowledge base provides the content to support your vital decision-making processes in biomedical research and development.
|
